Status:
COMPLETED
Study on Safety and Efficacy of an Oral Contraceptive in Long Cycles
Lead Sponsor:
Bayer
Conditions:
Contraception
Eligibility:
FEMALE
18-35 years
Phase:
PHASE3
Brief Summary
The purpose of the study is to determine safety and efficacy of long-cycle regimens of an oral contraceptive.
Detailed Description
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG (BSP AG), Germany. Bayer Schering Pharma AG, Germany is the sponsor of ...
Eligibility Criteria
Inclusion
- Healthy women who desire contraception
- smokers ≤ 30 Years old
Exclusion
- Contraindication against use of hormonal contraceptives
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
1166 Patients enrolled
Trial Details
Trial ID
NCT00266032
Start Date
December 1 2005
End Date
October 1 2008
Last Update
November 3 2014
Active Locations (35)
Enter a location and click search to find clinical trials sorted by distance.
1
Drummondville, Quebec, Canada, J2B 1H8
2
Montreal, Quebec, Canada, H1T 1P6
3
Pointe-Claire, Quebec, Canada, H9R 4S3
4
Québec, Quebec, Canada, G1S 2L6